Health and Human Services News and Research

RSS

NIH awards grants for using bioengineered models to improve clinical trial design

Clinical Trials on a Chip researchers plan to build and test common and rare disease models to help improve the clinical trial process.

30 Sep 2020

NIH-funded nationwide study seeks to discover the cause of rare forms of diabetes

A nationwide study funded by the National Institutes of Health will seek to discover the cause of several unusual forms of diabetes.

30 Sep 2020

Brain wiring genes may be linked to a significant portion of cerebral palsy cases

In an article published in Nature Genetics, researchers confirm that about 14% of all cases of cerebral palsy, a disabling brain disorder for which there are no cures, may be linked to a patient's genes and suggest that many of those genes control how brain circuits become wired during early development.

28 Sep 2020

FDA releases final guidance to improve patient communication about risks of breast implants

Today, the U.S. Food and Drug Administration issued the final guidance, "Breast Implants - Certain Labeling Recommendations to Improve Patient Communication," as part of the agency's effort to help improve the information available to patients and health care professionals about the risks of breast implants.

28 Sep 2020

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

25 Sep 2020

FDA issues updated recommendations concerning dental amalgam

Part of our role in protecting patients is to regularly evaluate, monitor and update scientific evidence on the risks from medical devices—including issues related to the materials used in devices, such as metals.

25 Sep 2020

New study may explain why more men than women die from COVID-19

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease.

25 Sep 2020

UNH awarded $1.8 million NIH grant to advance molecular research in diabetes and cancer

The University of New Hampshire will receive $1.8 million from the National Institutes of Health that will further molecular research to better understand drug interactions at the cellular level and help lead to the development of new targeted drugs to treat wide-spread metabolic, growth, neurological and visual disorders including diabetes and cancer.

24 Sep 2020

FDA takes actions to help provide safe, more affordable drugs to Americans

Today, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration took actions to help provide safe, effective, and more affordable drugs to American patients as part of the Safe Importation Action Plan, fulfilling the aspect of the July Executive Order on drug pricing to complete the rulemaking to allow states to import certain prescription drugs from Canada.

24 Sep 2020

These secret safety panels will pick the COVID vaccine winners

Most Americans have never heard of Dr. Richard Whitley, an expert in pediatric infectious diseases at the University of Alabama-Birmingham.

24 Sep 2020

FDA finalizes molluscan shellfish equivalence determination for two EU Member States

Today, the U.S. Food and Drug Administration finalized a molluscan shellfish equivalence determination for two European Union (EU) Member States, Spain and the Netherlands.

24 Sep 2020

FDA issues emergency use authorization for first serology point-of-care test for COVID-19

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.

24 Sep 2020

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers.

23 Sep 2020

FDA announces requirement of class-wide labeling changes for benzodiazepines

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency's most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.

23 Sep 2020

Researchers explore clinical and biological aspects of myalgic encephalomyelitis/chronic fatigue syndrome

One of the major symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is post-exertional malaise (PEM), the worsening of symptoms after physical or mental activities.

23 Sep 2020

FDA proposes updates to clarify evidence related to 'intended use' of FDA-regulated products

Today, we proposed updates to our regulations to clarify the types of evidence the FDA considers when determining the "intended use" of a product.

22 Sep 2020

FDA establishes the Digital Health Center of Excellence

Today, the U.S. Food and Drug Administration announced it is launching the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH).

22 Sep 2020

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.

22 Sep 2020

Middle-aged people report more pain than older Americans, study finds

A new study finds middle-aged Americans are now reporting more pain than the elderly -- and it has to do with their level of education and that pain is rising more quickly in younger people.

22 Sep 2020

Belief in pandemic conspiracy theories is an obstacle to minimize the spread of COVID-19

Belief in conspiracy theories about the coronavirus pandemic is not only persistent but also is associated with reluctance to accept a COVID-19 vaccine when one becomes available and to engage in behaviors such as mask-wearing that can prevent its spread, according to researchers at the Annenberg Public Policy Center.

22 Sep 2020

Health and Human Services News and Research

NIH awards grants for using bioengineered models to improve clinical trial design

NIH-funded nationwide study seeks to discover the cause of rare forms of diabetes

Brain wiring genes may be linked to a significant portion of cerebral palsy cases

FDA releases final guidance to improve patient communication about risks of breast implants

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

FDA issues updated recommendations concerning dental amalgam

New study may explain why more men than women die from COVID-19

UNH awarded $1.8 million NIH grant to advance molecular research in diabetes and cancer

FDA takes actions to help provide safe, more affordable drugs to Americans

These secret safety panels will pick the COVID vaccine winners

FDA finalizes molluscan shellfish equivalence determination for two EU Member States

FDA issues emergency use authorization for first serology point-of-care test for COVID-19

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

FDA announces requirement of class-wide labeling changes for benzodiazepines

Researchers explore clinical and biological aspects of myalgic encephalomyelitis/chronic fatigue syndrome

FDA proposes updates to clarify evidence related to 'intended use' of FDA-regulated products

FDA establishes the Digital Health Center of Excellence

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

Middle-aged people report more pain than older Americans, study finds

Belief in pandemic conspiracy theories is an obstacle to minimize the spread of COVID-19

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News